Correlation Between Crinetics Pharmaceuticals and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Monte Rosa.
Diversification Opportunities for Crinetics Pharmaceuticals and Monte Rosa
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Crinetics and Monte is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Monte Rosa go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Monte Rosa
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.48 times more return on investment than Monte Rosa. However, Crinetics Pharmaceuticals is 2.1 times less risky than Monte Rosa. It trades about 0.0 of its potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 5,715 in Crinetics Pharmaceuticals on August 29, 2024 and sell it today you would lose (38.00) from holding Crinetics Pharmaceuticals or give up 0.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Monte Rosa Therapeutics |
Crinetics Pharmaceuticals and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Monte Rosa
The main advantage of trading using opposite Crinetics Pharmaceuticals and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. Scpharmaceuticals | Crinetics Pharmaceuticals vs. Milestone Pharmaceuticals | Crinetics Pharmaceuticals vs. Seres Therapeutics |
| Monte Rosa vs. Eliem Therapeutics | Monte Rosa vs. Scpharmaceuticals | Monte Rosa vs. Milestone Pharmaceuticals | Monte Rosa vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |